Unique palliative care needs of patients with advanced chronic kidney disease - the scope of the problem and several solutions.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 18 1 2019
pubmed: 18 1 2019
medline: 17 3 2020
Statut: ppublish

Résumé

Patients with advanced chronic kidney disease (CKD), including end-stage renal disease (ESRD), have a life-threatening illness complicated by high morbidity and mortality and, therefore, should be suitable candidates for early intervention by palliative care specialists. However, the average patient with CKD does not have an advanced care plan, has multiple debilitating symptoms, and does not utilise hospice care at the end of life. In this review, we outline the scope of the problem of unmet palliative care needs for patients with advanced CKD and ESRD, barriers to improving palliative care for patients with renal failure, and possible future directions for palliative nephrology.

Identifiants

pubmed: 30651241
pii: 19/1/26
doi: 10.7861/clinmedicine.19-1-26
pmc: PMC6399628
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-29

Informations de copyright

© Royal College of Physicians 2019. All rights reserved.

Références

Circ Heart Fail. 2016 Jan;9(1):e002460
pubmed: 26699392
Kidney Int. 2006 May;69(9):1621-5
pubmed: 16672923
J Palliat Care. 1991 Summer;7(2):6-9
pubmed: 1714502
Palliat Med. 2018 Feb;32(2):395-403
pubmed: 28731382
J Pain Symptom Manage. 2018 Jan;55(1):108-116.e2
pubmed: 28803081
BMC Nephrol. 2018 Apr 24;19(1):96
pubmed: 29699499
Clin J Am Soc Nephrol. 2010 Jan;5(1):72-9
pubmed: 19965531
Palliat Med. 2014 Apr;28(4):360-6
pubmed: 24201135
Am J Kidney Dis. 2017 May;69(5):568-575
pubmed: 27856091
JAMA Intern Med. 2018 Jun 1;178(6):792-799
pubmed: 29710217
Am J Kidney Dis. 2018 Jun;71(6):866-873
pubmed: 29510920
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):1001-1009
pubmed: 28377472
Am J Kidney Dis. 2003 Oct;42(4):813-20
pubmed: 14520633
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):633-40
pubmed: 26988748
JAMA. 2012 May 2;307(17):1801-2
pubmed: 22492759
Nephrology (Carlton). 2016 Mar;21(3):241-53
pubmed: 26265214

Auteurs

Daniel Sturgill (D)

Medical College of Wisconsin, Milwaukee, USA dsturgill@mcw.edu.

Alexandria Bear (A)

Medical College of Wisconsin, Milwaukee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH